Vertex Pharmaceuticals (VRTX) Net Cash Flow Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 198.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 467.41% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14,223.53% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 453.08% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -125.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 453.08% |
| Dec 31, 2025 | 121.11% |
| Sep 30, 2025 | -104.75% |
| Jun 30, 2025 | 105.23% |
| Mar 31, 2025 | 106.97% |
| Dec 31, 2024 | 18.54% |
| Sep 30, 2024 | -35.65% |
| Jun 30, 2024 | -639.74% |
| Mar 31, 2024 | 3.35% |
| Dec 31, 2023 | -159.63% |
| Sep 30, 2023 | 92.86% |
| Jun 30, 2023 | -24.71% |
| Mar 31, 2023 | -251.69% |
| Dec 31, 2022 | 146.61% |
| Sep 30, 2022 | 134.88% |
| Jun 30, 2022 | 558.10% |
| Mar 31, 2022 | 146.89% |
| Dec 31, 2021 | -13.98% |
| Sep 30, 2021 | -58.08% |
| Jun 30, 2021 | -119.98% |